{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:59:02Z","timestamp":1792079942169,"version":"4.4.0"},"reference-count":39,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Prostate adenocarcinoma is characterized by substantial inter-patient heterogeneity, limiting the clinical reliability of conventional diagnostic tools, including prostate-specific antigen testing. This limitation underscores the need for robust molecular biomarkers that may complement conventional diagnostic tools, highlighting the urgent need for biomarkers capable of enhancing diagnostic accuracy and enabling more precise risk stratification. In the present study, transcriptomic data from The Cancer Genome Atlas (TCGA) were analyzed using an integrative bioinformatics and machine learning pipeline., The proposed workflow was designed as a stepwise and reproducible biomarker prioritization framework in which differential expression analysis, functional enrichment, protein\u2013protein interaction (PPI) based network interpretation, graph-convolutional feature selection, and hybrid ensemble machine learning were sequentially integrated. Differential gene expression analysis was combined with pathway enrichment (Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Reactome), protein\u2013protein interaction network construction, and graph-convolutional feature selection. Multiple machine learning algorithms, including Random Forest, Gradient Boosting Machine, Support Vector Classifier, Artificial Neural Network, and AdaBoost, were systematically evaluated. A hybrid ensemble model integrating Gradient Boosting Machine and Random Forest (GBM+RF) was subsequently developed. Model performance was assessed using accuracy, sensitivity, specificity, and area under the Receiver Operating Characteristic (ROC) and externally validated using the independent GSE14206 dataset. The analysis revealed a coordinated molecular pattern characterized by dysregulated cell cycle activity and enhanced interferon-mediated immune signaling. Protein\u2013protein interaction analysis identified STAT1 and PLK1 as highly connected network hub genes within immune-related and cell-cycle-associated modules. Among the evaluated models, the hybrid GBM+RF framework achieved the highest predictive performance on the TCGA dataset, with AUC: 0.9526; Accuracy: 97.49%. External validation using the GSE14206 dataset confirmed the robustness of this model (AUC: 0.9156; Accuracy: 91.53%). These findings support a broader multi-gene candidate signature in prostate adenocarcinoma, in which machine learning prioritized genes such as XAF1, APP, RPA3, IFIH1, UBE2D2, RSAD2, KIF2C, and PLK1, while STAT1 and PLK1 provided complementary network-level biological relevance. The proposed framework provides a robust and transferable strategy for biomarker discovery and precision oncology.<\/jats:p>","DOI":"10.3390\/ijms27156635","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:47:41Z","timestamp":1785145661000},"page":"6635","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative Bioinformatics and Machine Learning Analysis Identifies Novel Molecular Biomarkers in Prostate Adenocarcinoma"],"prefix":"10.3390","volume":"27","author":[{"given":"Hasan An\u0131l","family":"Kurt","sequence":"first","affiliation":[{"name":"Department of Urology, Faculty of Medicine, \u00c7anakkale Onsekiz Mart University, 17020 \u00c7anakkale, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9299-7141","authenticated-orcid":false,"given":"Sabire","family":"K\u0131l\u0131\u00e7arslan","sequence":"additional","affiliation":[{"name":"Department of Medical System Biology, Graduate School of Sciences, \u00c7anakkale Onsekiz Mart University, 17020 \u00c7anakkale, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-9717","authenticated-orcid":false,"given":"Meliha Merve","family":"\u00c7i\u00e7ekliyurt","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, \u00c7anakkale Onsekiz Mart University, 17020 \u00c7anakkale, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9483-4425","authenticated-orcid":false,"given":"Serhat","family":"K\u0131l\u0131\u00e7arslan","sequence":"additional","affiliation":[{"name":"Department of Software Engineering, Faculty of Engineering, Bandirma Onyedi Eyl\u00fcl University, 10200 Bal\u0131kesir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"110008","DOI":"10.1016\/j.compbiomed.2025.110008","article-title":"Machine learning prediction of overall survival in prostate adenocarcinoma using ensemble techniques","volume":"189","author":"Emegano","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"ref_2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1145\/3689207","article-title":"Smooth approximations: An algebraic approach to CSPs over finitely bounded homogeneous structures","volume":"71","author":"Mottet","year":"2024","journal-title":"J. ACM"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"67259","DOI":"10.1007\/s11042-023-17234-4","article-title":"Improved multi-layer hybrid adaptive particle swarm optimization based artificial bee colony for optimizing feature selection and classification of microarray data","volume":"83","year":"2023","journal-title":"Multimed. Tools Appl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent\u2014Update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"125927","DOI":"10.1016\/j.eswa.2024.125927","article-title":"Advanced Residual Transformer (ART) method for identification of bile duct dilatation on CT data","volume":"266","year":"2025","journal-title":"Expert Syst. Appl."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s12020-024-04068-9","article-title":"Identification of potential biomarkers of papillary thyroid carcinoma","volume":"87","author":"Kilicarslan","year":"2024","journal-title":"Endocrine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15330338241290029","DOI":"10.1177\/15330338241290029","article-title":"Advancements in Biomarkers of Prostate Cancer: A Review","volume":"23","author":"Gbadebo","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1158\/0008-5472.CAN-25-0269","article-title":"Combining spatial transcriptomics, pseudotime, and machine learning enables discovery of biomarkers for prostate cancer","volume":"85","author":"Smelik","year":"2025","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/s41598-025-32334-x","article-title":"Prostate cancer diagnosis using sensitive and sophisticated machine learning classifiers based on non-invasive urinary RNA biomarkers (PCASSO)","volume":"16","author":"Goh","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/1878-0261.13804","article-title":"Integration of single-cell and bulk RNA-sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer","volume":"19","author":"Mou","year":"2025","journal-title":"Mol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33076","DOI":"10.1038\/s41598-025-15682-6","article-title":"Integrative analysis of molecular mechanisms in prostate cancer via single-cell RNA sequencing and weighted gene co-expression network analysis","volume":"15","author":"Zhai","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e70806","DOI":"10.1111\/jcmm.70806","article-title":"Single-Cell and Bulk RNA Sequencing Highlights Intra-Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer","volume":"29","author":"Wu","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2417274","DOI":"10.1001\/jamanetworkopen.2024.17274","article-title":"Development of a longitudinal prostate cancer transcriptomic and clinical data linkage","volume":"7","author":"Leapman","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41391-022-00537-2","article-title":"The promising role of new molecular biomarkers in prostate cancer: From coding and non-coding genes to artificial intelligence approaches","volume":"25","author":"Scavuzzo","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dushimova, Z., Iztleuov, Y., Chingayeva, G., Shepetov, A., Mustapayeva, N., Shatkovskaya, O., Pashimov, M., and Saliev, T. (2025). Overdiagnosis and overtreatment in prostate cancer. Diseases, 13.","DOI":"10.3390\/diseases13060167"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12935-025-03788-w","article-title":"Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer","volume":"25","author":"Zhong","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1186\/s12967-025-06731-9","article-title":"An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer","volume":"23","author":"Han","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, X., Wang, F., Xu, X., Zhang, J., and Xu, G. (2021). The dual role of STAT1 in ovarian cancer: Insight into molecular mechanisms and application potentials. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.636595"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41389-020-00292-w","article-title":"Feedback activation of STAT3 limits the response to PI3K\/AKT\/mTOR inhibitors in PTEN-deficient cancer cells","volume":"10","author":"Wang","year":"2021","journal-title":"Oncogenesis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"85997","DOI":"10.18632\/oncotarget.20844","article-title":"STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer","volume":"8","author":"Mohanty","year":"2017","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41419-023-05694-3","article-title":"Inhibition of CDKL3 downregulates STAT1 thus suppressing prostate cancer development","volume":"14","author":"Jiang","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Danziger, O., Pupko, T., Bacharach, E., and Ehrlich, M. (2018). Interleukin-6 and Interferon-\u03b1 signaling via JAK1\u2013STAT differentially regulate oncolytic versus cytoprotective antiviral states. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00094"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Luo, Y., Yang, X., Basourakos, S.P., Zuo, X., Wei, D., Zhao, J., Li, M., Li, Q., Feng, T., and Guo, P. (2021). Enzalutamide-resistant progression of castration-resistant prostate cancer is driven via the JAK2\/STAT1-dependent pathway. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.652443"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Vitkin, N., Nersesian, S., Siemens, D.R., and Koti, M. (2019). The tumor immune contexture of prostate cancer. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00603"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network, Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R.M., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J.M. (2013). The cancer genome atlas pan-cancer analysis project. Nat. Genet., 45, 1113\u20131120.","DOI":"10.1038\/ng.2764"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rojas, R. (2024). AdaBoost and the Super Bowl of Classifiers a Tutorial Introduction to Adaptive Boosting. TechRxiv.","DOI":"10.36227\/techrxiv.172107276.63524590\/v1"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Sch\u00f6lkopf, B., Luo, Z., and Vovk, V. (2013). Explaining AdaBoost. Empirical Inference, Springer.","DOI":"10.1007\/978-3-642-41136-6"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17849\/insm-47-01-31-39.1","article-title":"Random forest","volume":"47","author":"Rigatti","year":"2017","journal-title":"J. Insur. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1022627411411","article-title":"Support vector machine","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach. Learn."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"An-na, W., Yue, Z., Yun-tao, H., and Yun-lu, L.I. (2010). A novel construction of SVM compound kernel function. Proceedings of the 2010 International Conference on Logistics Systems and Intelligent Management (ICLSIM), IEEE.","DOI":"10.1109\/ICLSIM.2010.5461210"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kurt, H.A., K\u0131l\u0131\u00e7arslan, S., and \u00c7i\u00e7ekliyurt, M.M. (2026). Explainable Machine Learning-Based Overall Survival Classification in Prostate Adenocarcinoma Using Integrated Clinical and Transcriptomic Features. Diagnostics, 16.","DOI":"10.3390\/diagnostics16091345"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.1016\/j.jfranklin.2021.10.005","article-title":"Random radial basis function kernel-based support vector machine","volume":"358","author":"Ding","year":"2021","journal-title":"J. Frankl. Inst."},{"key":"ref_37","first-page":"18","article-title":"C5. 0 algorithm to improved decision tree with feature selection and reduced error pruning","volume":"117","author":"Pandya","year":"2015","journal-title":"Int. J. Comput. Appl."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-4899-7641-3_10","article-title":"Decision Tree Learning","volume":"Volume 36","author":"Suthaharan","year":"2016","journal-title":"Machine Learning Models and Algorithms for Big Data Classification"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12672-025-04369-z","article-title":"Bioinformatics and machine learning integration reveals a novel 4-gene (GFUS, ARHGAP8, NBL1, and ACTB) biomarker model for prostate cancer","volume":"17","author":"Kilicarslan","year":"2026","journal-title":"Discov. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6635\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:51:09Z","timestamp":1785145869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":39,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156635"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156635","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]}}}